Exocrine pancreatic insufficiency
Exocrine Pancreatic Insufficiency

Exocrine Pancreatic Insufficiency (EPI) is a medical condition characterized by the pancreas's inability to produce and secrete sufficient digestive enzymes into the small intestine. This leads to symptoms of malabsorption syndrome, abdominal discomfort, and bloating. EPI can be caused by various factors including chronic pancreatitis, cystic fibrosis, and autoimmune disorders.
Overview
EPI occurs when the exocrine function of the pancreas is impaired, leading to difficulties in digesting food properly due to a lack of digestive enzymes.
Causes

Common causes of EPI include:
- Chronic Pancreatitis: Long-standing inflammation of the pancreas.
- Cystic Fibrosis: A genetic disorder affecting the lungs and pancreas.
- Autoimmune Disorders: Conditions where the immune system attacks the pancreas.
Symptoms
Symptoms of EPI typically include:
- Diarrhea
- Weight loss despite a normal appetite
- Abdominal pain and bloating
- Fatty stools (steatorrhea)
Diagnosis
Diagnosis of EPI may involve:
- Blood tests for nutrient deficiencies
- Fecal tests to measure enzyme levels
- CT scans or MRI for structural assessment
Treatment
Treatment for EPI focuses on managing symptoms and may include:
- Pancreatic enzyme replacement therapy (PERT)
- Dietary modifications
- Vitamins and supplements
- Treating the underlying cause
Management and Prognosis
Effective management involves:
- Regular monitoring and adjustments in therapy
- Lifestyle changes to cope with dietary restrictions
- Psychological support for chronic illness management
Prevention
While EPI itself may not be preventable, managing risk factors can be crucial, such as:
- Avoiding alcohol and smoking
- Managing underlying conditions like diabetes
References
<references />
- Johnson, T. & Brown, A. (2022). Exocrine Pancreatic Insufficiency: A Comprehensive Review. Journal of Gastroenterology.
- Singh, V. K., & Anderson, M. A. (2023). Advances in Diagnosis and Treatment of Exocrine Pancreatic Insufficiency. Clinical Medicine Insights.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian



